tm logo

Monitor this mark

View On USPTO

ARRAKIS THERAPEUTICS
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 04 Sep 2024

Last Applicant/ Owned by

Arrakis Therapeutics, Inc

828 Winter Street

Waltham

MA

02451

Serial Number

90265729 filed on 20th Oct 2020

Registration Number

N/A

Correspondent Address

Glenn A. Gundersen

Glenn A. Gundersen DECHERT LLP

PHILADELPHIA, PA 19104-2808

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ARRAKIS THERAPEUTICS

Pharmaceutical preparations, namely, small-molecule drugs

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, small-molecule drugs

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 90265729

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 176694-003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.15 -

Three circles

26.01.17 -

Two concentric circles

26.01.21 -

Circles that are totally or partially shaded

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History

Show more

Status DateAction Taken
04th Sep 2024SOU EXTENSION 5 FILED
04th Sep 2024SOU EXTENSION 5 GRANTED
04th Sep 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th Sep 2024SOU TEAS EXTENSION RECEIVED
22nd Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Feb 2024SOU TEAS EXTENSION RECEIVED
21st Feb 2024SOU EXTENSION 4 FILED
21st Feb 2024SOU EXTENSION 4 GRANTED
08th Sep 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06th Sep 2023SOU EXTENSION 3 GRANTED